CBD Global Sciences Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CBDN.CN research report →
Companywww.cbdglobalsciences.com
CBD Global Sciences Inc. engages in cannabidiol (CBD) farming, processing, and product manufacturing business. It offers biomass, CBD oil, and CBD oil products under the Aethics, CannaOil, and Strasburg Pharms brand names.
- CEO
- Brad Wyatt
- IPO
- 2019
- HQ
- Lakewood, CO, US
Price Chart
Valuation
- Market Cap
- $2.23M
- P/E
- -0.20
- P/S
- 9.68
- P/B
- -0.69
- EV/EBITDA
- -0.86
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 24.56%
- Op Margin
- -1641.21%
- Net Margin
- -3469.40%
- ROE
- 116.17%
- ROIC
- -391.67%
Growth & Income
- Revenue
- $166.95K · -45.33%
- Net Income
- $-5,792,058 · 42.48%
- EPS
- $-0.16 · 50.00%
- Op Income
- $-2,739,944
- FCF YoY
- 14.79%
Performance & Tape
- 52W High
- $0.16
- 52W Low
- $0.03
- 50D MA
- $0.04
- 200D MA
- $0.04
- Beta
- 0.43
- Avg Volume
- 0
Get TickerSpark's AI analysis on CBDN.CN
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our CBDN.CN Coverage
We haven't published any research on CBDN.CN yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate CBDN.CN Report →